Can HCV Be Eradicated in Persons Who Inject Drugs?

Dr. Jason Grebely

Dr. Jason Grebely

Associate Professor & NHMRC Career Development
(Kirby Institute, UNSW Faculty of Medicine, Sydney, Australia)

This talk is open to the public
A light lunch will be served

For more information, please contact
education@cfenet.ubc.ca / local 63219

The Forefront Lectures are accredited for 1.0 Mainpro-M1 credit (College of Family Physicians of Canada)


Dr. Jason Grebely is an Associate Professor in the Viral Hepatitis Clinical Program at the Kirby Institute in the Faculty of Medicine at UNSW Australia in Sydney. Jason completed his BSc in Biochemistry and Molecular Biology and his PhD in Pharmacology at the University of British Columbia in Vancouver, Canada. He then moved to Australia where he completed a Post Doctoral Fellowship in Clinical Epidemiology at the Kirby Institute, University of New South Wales with Professor Gregory Dore. Jason now continues to work in Australia as an Associate Professor and NHMRC Career Development Fellow at the Kirby Institute, but maintains close collaborations with his Canadian colleagues. Research interests include epidemiology, natural history and therapeutic strategies for acute and chronic HCV infection in people who inject drugs.

Jason Grebely


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below